Our policy work
Last modified: 9 July 2025, 17:54
Our vision is of a day when cervical cancer is eliminated. Until then, we will campaign for excellence in the diagnosis, prevention, treatment, and care of those affected by cervical cancer and cervical cell changes.
Eliminating cervical cancer
The UK has the tools to make cervical cancer a thing of the past, and we’re calling for government action to make this happen as soon as possible. We want to see action to tackle the inequalities in cervical cancer prevention and diagnosis, NHS systems and workforces that are future-proofed, and research to improve the treatment and care provided.
Read our report on the challenges and opportunities to eliminating cervical cancer in the UK >
Access to treatment for advanced cervical cancer
We’re calling for more research and access to treatments for advanced cervical cancer. Find out more about our current campaign >
Research and reports
We amplify the voices of patients and share best practice with healthcare professionals, to improve women’s experiences of cervical cancer prevention and treatment.
Recent consultation responses
By responding to consultations, we help shape government strategies around cancer diagnosis and treatment, women’s health, and long-term healthcare planning.
- 2023: Disability Action Plan 2023 to 2024
- 2023: Health and Social Care Committee: Future cancer inquiry
- 2023: Health and Social Care Committee: Inquiry into prevention in health and social care
- 2023: Welsh Senedd consultation on gynaecological cancers
- 2022: 10-Year Cancer Plan call for evidence: Jo’s Cervical Cancer Trust written response
- 2022: 10 Year Cancer Plan: One Cancer Voice consensus statement
- 2022: Scottish Government New Cancer Strategy consultation
- 2021: Cancer Strategy in Northern Ireland
- 2021: The Department of Health and Social Care’s development of a Women’s Health Strategy
We routinely respond to consultations from the National Institute for Health & Care Excellence (NICE), the Scottish Medicines Consortium (SMC), the All Wales Medicines Strategy Group (AWMSG), and the Joint Committee on Vaccination and Immunisation (JCVI) in order to shape decisions on the provision of cancer drugs and HPV vaccination strategies.
The HPV Coalition
The HPV Coalition launched in 2022 and is an expert advisory group of leading patient groups, professional groups, clinicians, and expert individuals who have come together to inform and advance the UK’s journey towards the elimination of HPV-related cancers. Jo’s are proud to be one of the co-chairs of the Coalition, with our CEO Samatha Dixon sitting alongside David Winterflood, CEO of NOMAN.
Together, we have launched a roadmap to eliminate all HPV-related cancers in the UK. Read more about it here >
We play an active role in many policy-related groups:
- Cancer 52
- Cancer52 menopause and cancer working group
- Cancer52 cancer inequalities working group
- HPV Action Network
- HPV Coalition
- One Cancer Voice
England
- All Party Parliamentary Group on Cancer
- All Party Parliamentary Group on Women’s Health
- Cervical Screening Programme Board
- HPV Self-Sampling Board
- NHS England Cancer Charity Forum
- NHS England Colposcopy Services Review Task and Finish Group
Northern Ireland
- All Party Group on Cancer
- All Party Group on Women’s Health
- HPV Primary Screening Implementation Working Group
Scotland
- Cervical Screening Programme Board
- Cross-Party Group on Cancer
- Cross-Party Group on Women’s Health
- Core Screening Standards Development Group
- Equity in Screening Strategy Advisory Group
- Scottish Cancer Coalition
- Scottish Cancer Coalition Early Diagnosis and Screening Subgroup
- Scottish Cervical Screening Expert Review Group
Wales
- Cervical Screening Programme Board
- Cross Party Group on Cancer
- Cross Party Group on Women’s Health
- Wales Cancer Alliance
- Women’s Health Wales Coalition
Computer says “no”
Our report highlights the growing issue of access to cervical screening across the UK, the problems and how they can be overcome.
Our research
Our latest research covers awareness of cervical screening, understanding of HPV and the patient experience of having cell changes or cervical cancer